THE POWER OF PROTEINS IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY

A Brief Overview of Proteomics and It's Industrial Applications

  Enroll in Course

There has been a rapid growth in the biopharmaceutical industry propelled by the influence of the biotechnology sector, since the FDA approval of the first recombinant human therapeutic protein. This innovation driver and its fast growth has created a need for constant scientific training of engineers, scientists, operators, corporate and sales professionals involved in the discovery and development of biomedicines. With the increasing number of drugs in phase III clinical trials being proteins, the emerging field of proteomics and the advancement of its technological tools would certainly impact the drug targets, strategies and even the economic interests of the pharma and biotech industries. This course, provides the participant with a broad understanding of protein concepts and structure, recombinant protein expression, an introduction to proteomics, its types and applications and the current methodology available to analyze and identify proteins. We will briefly touch on the FDA guidelines for drug development and approval of therapeutic proteins and will discuss a case study of biologicals using the scientific literature.

This course is ideal for undergraduate and graduate students, professionals, technicians, operators, and sales personnel in the biotech and pharma industries who want to expand their current knowledge about the biochemistry of proteins and the field of proteomics.


Your Instructor


Frances M. Gratacos, Ph.D.
Frances M. Gratacos, Ph.D.

Frances is a Scientist and Administrator with 15 years of basic research experience in Molecular Biosciences with a focus in Immunology, Biochemistry and Cancer Biology. Her expertise spans the regulation of gene expression at the mRNA level, protein-protein interactions, signaling pathways, stem cell differentiation and vitamin A metabolism. She is a graduate of the Biotechnology program at the University of Puerto Rico Mayaguez Campus. She later completed a PhD in Molecular Biology at Rutgers/UMDNJ under a Biotechnology Training Program Grant and a NSF-IGERT Fellowship, and a Postdoc in Pharmacology at Weill Cornell Medical College. She co-authored (jointly with Gary Brewer) The Role of AUF1 in regulated mRNA decay, (jointly with Ania Knapinska) Chaperone Hsp27 Modulates AUF1 Proteolysis and AU-Rich Element-Mediated mRNA Degradation and contributed to Chaperone Hsp27, a Novel Subunit of AUF1 Protein Complexes, Functions in AU-Rich Element-Mediated mRNA Decay. Frances also have ample experience in the field of International Higher Education and has administered several Education Programs in South America. She is an experienced speaker and presenter of research findings at scientific conferences and education topics at National and International Education seminars, conferences and conventions.


Frequently Asked Questions


When does the course start and finish?
The course starts now and never ends! It is a completely self-paced online course - you decide when you start and when you finish.
How long do I have access to the course?
How does lifetime access sound? After enrolling, you have unlimited access to this course for as long as you like - across any and all devices you own.
What if I am unhappy with the course?
We would never want you to be unhappy! If you are unsatisfied with your purchase, contact us in the first 30 days and we will give you a full refund.

Get started now!